| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
CANB Stock Overview
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States.
Can B Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.50 |
| 52 Week High | US$9.60 |
| 52 Week Low | US$1.02 |
| Beta | 0.79 |
| 1 Month Change | -36.17% |
| 3 Month Change | -57.14% |
| 1 Year Change | -80.02% |
| 3 Year Change | -97.57% |
| 5 Year Change | -98.44% |
| Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| CANB | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -21.1% | -0.3% | -2.8% |
| 1Y | -80.0% | 14.1% | -19.6% |
Return vs Industry: CANB underperformed the US Pharmaceuticals industry which returned 13.4% over the past year.
Return vs Market: CANB underperformed the US Market which returned -21.2% over the past year.
Price Volatility
| CANB volatility | |
|---|---|
| CANB Average Weekly Movement | 28.5% |
| Pharmaceuticals Industry Average Movement | 11.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: CANB is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 28% a week.
Volatility Over Time: CANB's weekly volatility has increased from 22% to 28% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 68 | Marco Alfonsi | https://canbcorp.com |
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands.
Can B Corp. Fundamentals Summary
| CANB fundamental statistics | |
|---|---|
| Market Cap | US$6.37m |
| Earnings (TTM) | -US$16.04m |
| Revenue (TTM) | US$8.00m |
0.8x
P/S Ratio-0.4x
P/E RatioIs CANB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANB income statement (TTM) | |
|---|---|
| Revenue | US$8.00m |
| Cost of Revenue | US$3.99m |
| Gross Profit | US$4.02m |
| Other Expenses | US$20.06m |
| Earnings | -US$16.04m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.78 |
| Gross Margin | 50.20% |
| Net Profit Margin | -200.42% |
| Debt/Equity Ratio | 168.2% |
How did CANB perform over the long term?
See historical performance and comparison